Recommended pre-submission checks
Powered by 

Ibero Latin American Journal of Health System Pharmacy Journal Specifications
| Overview | |
| Publisher | Organización Farmacéutica Ibero Latinoamericana |
| Language | Spanish,Portuguese,English |
| Publication Time | 12 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 12 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Dulcinea |
| License type | Publisher's own license |
| OA statement | Visit website |
View less
Planning to publish in Ibero Latin American Journal of Health System Pharmacy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Ibero Latin American Journal of Health System Pharmacy
Outsourcing: yes, but...
- 1 Mar 2020
- Revista de la OFIL
Analysis and improvement of preparation and handling of hazardous oral drugs in a Hospital Pharmacy Department
- 1 Mar 2020
- Revista de la OFIL
Combined therapy with bevacizumab and alteplasa for the treatment of submacular hemorrhages
- 1 Mar 2020
- Revista de la OFIL
Cold chain quality assurance in pharmaceutical distribution
- 1 Mar 2020
- Revista de la OFIL
We make it to Volume 30 with the effort of many of us!
- 1 Mar 2020
- Revista de la OFIL
Datos en vida real a largo plazo de dupilumab en dermatitis atópica
- 1 Mar 2020
- Revista de la OFIL
Outsourcing: yes, but...
- 1 Mar 2020
- Revista de la OFIL
Analysis and improvement of preparation and handling of hazardous oral drugs in a Hospital Pharmacy Department
- 1 Mar 2020
- Revista de la OFIL
Combined therapy with bevacizumab and alteplasa for the treatment of submacular hemorrhages
- 1 Mar 2020
- Revista de la OFIL
Cold chain quality assurance in pharmaceutical distribution
- 1 Mar 2020
- Revista de la OFIL
We make it to Volume 30 with the effort of many of us!
- 1 Mar 2020
- Revista de la OFIL
Datos en vida real a largo plazo de dupilumab en dermatitis atópica
- 1 Mar 2020
- Revista de la OFIL